Zhicheng Huang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Small Cell Lung Cancer

Tyrosine Kinase

Systematic Review

Metastatic Colorectal Cancer

Top Venues

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Zhicheng Huang, Yadong Wang, Bowen Li, Yuan Xu, Guanghua Huang, Yang Song, Ji Li, Lan Song, Jinhua Wang, Rongxi Wang, Naixin Liang, Shan-Qing Li
Neoadjuvant BRAF and MEK inhibitor therapy elicits pathological complete response in stage IIIA non-small cell lung cancer harboring BRAF V600E mutation: A case report. Thoracic cancer 15 (24) (2024)
Bowen Li, Zhicheng Huang, Yadong Wang, Chao Guo, Naixin Liang, Huaxia Yang, Shan-Qing Li
Causal relationships between immune cell phenotypes and lung adenocarcinoma: A bidirectional two-sample Mendelian randomization study. Thoracic cancer 15 (21) (2024)
Zhicheng Huang, Yadong Wang, Bowen Li, Yuan Xu, Guanghua Huang, Yang Song, Ji Li, Lan Song, Jinhua Wang, Rongxi Wang, Naixin Liang, Shan-Qing Li
Neoadjuvant BRAF and MEK inhibitor therapy elicits pathological complete response in stage IIIA non-small cell lung cancer harboring BRAF V600E mutation: A case report. Thoracic cancer (2024)
Zhicheng Huang, Yadong Wang, Bowen Li, Yuan Xu, Guanghua Huang, Yang Song, Ji Li, Lan Song, Jinhua Wang, Rongxi Wang, Naixin Liang, Shan-Qing Li
Neoadjuvant BRAF and MEK inhibitor therapy elicits pathological complete response in stage IIIA non-small cell lung cancer harboring BRAF V600E mutation: A case report. Thoracic cancer 15 (24) (2024)
Zhicheng Huang, Yadong Wang, Bowen Li, Yuan Xu, Guanghua Huang, Yang Song, Ji Li, Lan Song, Jinhua Wang, Rongxi Wang, Naixin Liang, Shan-Qing Li
Neoadjuvant BRAF and MEK inhibitor therapy elicits pathological complete response in stage IIIA non-small cell lung cancer harboring BRAF V600E mutation: A case report. Thoracic cancer 15 (24) (2024)
Bowen Li, Zhicheng Huang, Yadong Wang, Chao Guo, Naixin Liang, Huaxia Yang, Shan-Qing Li
Causal relationships between immune cell phenotypes and lung adenocarcinoma: A bidirectional two-sample Mendelian randomization study. Thoracic cancer 15 (21) (2024)
Bowen Li, Zhicheng Huang, Yadong Wang, Chao Guo, Naixin Liang, Huaxia Yang, Shan-Qing Li
Causal relationships between immune cell phenotypes and lung adenocarcinoma: A bidirectional two-sample Mendelian randomization study. Thoracic cancer 15 (21) (2024)
Kexin Zhang, Zhicheng Huang, Yadong Wang, Jianchao Xue, Naixin Liang, Zewen Wei
Rapid determination of the presence of EGFR mutations with DNA-based nanocalipers. Nanoscale (2023)
Jianchao Xue, Bowen Li, Yadong Wang, Zhicheng Huang, Xinyu Liu, Chao Guo, Zhibo Zheng, Naixin Liang, Xiuning Le, Shan-Qing Li
Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Combination Therapy as First-Line Treatment for Patients with Advanced EGFR -Mutated, Non-Small Cell Lung Cancer: A Systematic Review and Bayesian Network Meta-Analysis. Cancers 14 (19) (2022)